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1. Introduction 
Hepatocellular carcinoma (HCC) is the most frequent primary neoplasia of the liver and its 
incidence has risen  and mainly affects subjects with cirrhosis. Globally, the main risk factor 
for HCC is hepatitis B virus linked or not to aflatoxin (1). Nevertheless, in industrialised 
countries, the most frequent risk factors associated with HCC are chronic infection caused 
by hepatitis C virus and ethanol ingestion (2). 
In the treatment of HCC, besides the size and number of nodules, also involved the patient's 
clinical status assessed by different methods (Child-Pough classification, MELD, ECOG 
performans status, indocyanine green levels, etc). Recently, the Barcelona Clinic group (3) 
provides a staging classification using the Child-Pough classification, performans status, 
Okuda classification, and evaluate the presence of portal hypertension and bilirubin 
levels.In the initial stages, the treatment options include: resection, liver transplant and 
ablation. In subjects with compensated cirrhosis, candidates for resection must be selected 
carefully and the liver function reserve must be tested (4). The best candidates for surgery 
are those with single tumours, those who present normal bilirubin and no clinically 
significant portal hypertension (5). HCC vascularisation is predominantly arterial and this 
establishes a specific vascular pattern characterised by intense contrast uptake in the arterial 
phase, followed  by  rapid wash out in the portal phase (6). Nevertheless, given that tumour 
spread via the veins originates in the area immediately surrounding the tumour, from an 
oncological point of view, it is worth performing a resection with a margin of 1 cm.  
Despite the strict selection process, the recurrence rate for this disease is very high and can 
reach 70 % after 5 years (4), recurrences of which, 70 %  correspond to intrahepatic metastasis, 
that were not detected when the resection was carried out, and 30%  are de novo HCC (7,8). 
On the basis of this, it was established that when liver transplants are limited to those subjects 
with single tumours that measure 5 cm or less or with a maximum of 3 nodules which 
measure less than 3 cm and that do not present vascular invasion or extrahepatic 
dissemination, a 4-year survival rate of 75 % and a recurrence rate of 8 % is obtained (9). 
In subjects with decompensated cirrhosis of the liver, resection is formally contraindicated 
and a liver transplant must be considered. In subjects with intermediate stage HCC (stage B 
according to HCC classification), the only treatment that has proven to be beneficial in terms 
www.intechopen.com
 
Advanced Laparoscopy 
 
150 
of survival outcome is transarterial chemoembolization (TACE) (10-13). However, despite 
the radiological treatment response obtained, in over half the cases, the main disadvantage 
was that most of the subjects experienced development of the disease despite the initial 
response. This treatment focuses on the predominantly arterial vascularisation of the HCC. 
It involves the selective catheterization of the hepatic artery, injecting a chemotherapy agent 
that is embedded inside a transport medium (usually lipiodol) and occluding the arterial 
flow afterwards with different embolizing substances.  
Moreover, laparoscopic liver resection (LLR) of hepatocellular carcinoma (HCC) on cirrhosis 
is generally indicated in Child A patients with tumours minor than 5 cm located in the 
peripheral segments (14) and more rarely in the right posterior segments. Given the special 
nature of the liver and the cirrhotic patient, LLR involves a high risk of bleeding and could 
require the use of the Pringle maneuver. Both events (hemorrhage and use of the Pringle 
maneuver) could cause postoperative liver failure, the main cause of death after liver 
resection (LR) in child A patients. 
Preoperative transarterial chemoembolization (TACE) has until now been used in large 
HCC with two objectives: (a) to increase resectability  or liver transplantation, by achieving 
understaging, and (b) to increase survival, by decreasing recurrence rates. However, given 
that HCC is a tumour that is mainly irrigated through the artery, preoperative TACE could 
decrease vascularization in the segments to be resected, and therefore reduce the risk of 
hemorrhage during liver resection. Consequently, the use of preoperative TACE could be 
recommended in early onset tumours, especially when they are going to be resected 
laparoscopically.  
2. Laparoscopic surgical technique 
2.1 Pure laparoscopic hepatectomy (PLP) 
The patient is placed in the decubitus supine position, independent of the location of the 
lesion, with the legs apart and slight bent over the pelvis. The surgeon stands between the 
patient’s legs and the first assistant to the left, with the second assistant to the patient’s right 
using a second monitor. Five trocars are used (four 10-mm and one 12-mm), 4 of them 
following a concave line to the lesion. After creation of the pneumoperitoneum (12 mmHg 
of CO2), either with a verres needle or with optiview, a 10-mm trocar is placed at the 
umbilicus for insertion of the straight telescope, and the 4 remaining trocars are placed 
under direct visual guidance. 
The first and second (10-mm) to the left and the right of the umbilical trocar; the next (10-
mm) in the left flank, on the mid axillary line, to insert the clamp for the Pringle 
manoeuvre; and the remaining in the subxiphoid areas to insert the liver separation 
forceps or for a better view of the suprahepatic veins and posterior hepatic ligaments. An 
intraoperative laparoscopic ultrasonography is performed using a probe  inserted through 
the 10-mm trocar. 
After necessary mobilisation of the liver the lesser omentum is dissected for control of the 
hepatic pedicle. Dissection of the hepatic parenchyma is done with 10-mm Ligasure Atlas 
(Tyco) or harmonic scalpel (Ethicon). When the hepatectomy is finished, the haemostasis 
is completed with Tissuelink (Primm). Following, any possible bile leaks are sutured, a 
haemostatic substance is applied to the surgical bed and an aspiration drain is placed on the 
surgical bed. The tumour specimen is extracted via a Pfannestiel incisión, without 
fragmenting so that the resection margins can be checked (15,16).  
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a)     b) 
Fig. 1. a) Pure laparoscopic surgery; b) Aesthetic results  
 
 
a)     b) 
Fig. 2. Echography probe a) Laparoscopic probe; b) Hand-assisted probe 
2.2 Hand Assisted Laparoscopic Surgery (HALLS) 
In cases of conversion to a (15,16), the position of  the patient and the assistants is the 
same as with PLP. The operation is begun with a transverse incision in the right flank, 
3-5 fingerwidths from the right costal edge (from the mid axillary line to the anterior 
axillary line). 
Abdominal muscles are dissected to reach the anterior sheath of the rectus, which is 
generally opened in few centimetres, and the hand-port is inserted. With the surgeon’s left 
hand inside the abdomen a 10-mm trocar is inserted into an adhesion-free area, the 
pneumoperitoneum is created (12 mmHg CO2) and the 4 remaining trocars are then placed 
in the same location and with the same function as in PLP. Subsequently a sonography is 
performed with an abdominal probe inserted via the hand-port. The surgical specimen is 
extracted through the hand-port incision in the right flank.  
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Fig. 3.1 Hand-assisted laparoscopic liver surgery 
 
 
Fig. 3.2 Aesthetic results 
3. Preoperative TACE technique 
In 2 cases the procedure involved selective catheterization of the hepatic artery followed 
by an injection of adriamycin embedded in lipiodol and arterial flow occlusion using 
spongostan. In the other 8 cases, we used polivinyl alcohol spheres loaded with 
adriamycin (17).  
4. Our experience 
We have shown the immediate intra and postoperative results of 10 cirrhotic Child A 
patients with HCC stages 0 and A according to the Barcelona Liver Cancer Classification (3). 
These patients were given TACE prior to LLR. 
Between January 1996 and December 2010 we performed 720 LR on solid liver tumours, of 
which 100 were by laparoscopy. LLR was carried out on 10 patients with HCC on cirrhosis 
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using a preoperative TACE, which was applied in order to decrease intraoperative bleeding 
(Table 1). All patients were Child A cirrhosis, without portal hypertension (normal platelets, 
gastroscopy without varices and no splenomegaly) and a normal total bilirubin. After 3 
weeks of TACE, a routine CT-scan showed tumour response to the treatment and scarce 
vascularization of embolized segments. 
 
 
Fig. 4. TACE: we can see the tumor and where arterial occlusion is performed 
 
Sex , years Etiology Nodules
Size 
(cm) 
Location Technique
Conversion 
to HALLS
Surgical 
time/ 
minutes
Blood 
loss 
Morbidity 
Male, 75 C Virus 1 4 VI-VII VI-VII No 210 150 No 
Male, 66 Alcohol 1 3 III III No 240 100 No 
Male, 60 Alcohol 2 3 and 2
VI + 
 
VII 
VI + 
 
RF VII 
Yes, for RF 
S. VIII 
240 200 No 
Female, 53 C Virus 1 5 V V 
Yes, for 
adherencial 
block 
150 150 No 
Male, 60 Alcohol 1 3 Left lobe LLS No 180 300 Ascitis 
Male, 82 Alcohol 1 5 VI VI No 150 500 Ascitis 
Female, 60 B Virus 1 4 VI-VII VI-VII No 120 100 No 
Male, 71 Alcohol 1 3 III III No 180 70 No 
Male, 72 Alcohol 1 3 III III No 150 100 No 
Male, 74 Alcohol 1 2 VI VI No 120 50 No 
Table 1. Characteristics of the 10 patients with the TACE protocol prior to laparoscopic 
resection until December 2010 
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Fig. 5. The CT scan shows tumor necrosis and ischemia of the right lateral sector 
The surgical technique performed was: bisegmentectomy VI-VII in 2 cases, segmentectomy 
VI in 3 cases (in 1 case we associated radiofrequency of a tumour located in segment VII, 
near to right hepatic vein), segmentectomy III in 3 cases, in 1 case segmentectomy V and left 
lateral sectionectomy in 1 case.  No Pringle maneuver was used. No patients were 
transfused. There was no postoperative mortality. Two patients presented postoperative 
ascites that was resolved with medical treatment. The mean hospital stay was 3.7 days 
(range 2-12 days). 
5. Comments 
For most authors, HCC involves several surgical difficulties for laparoscopic approach (14-
16, 18-27), especially in the cirrhotic liver (14,18,19, 24.25) due to the increased hardness of 
the liver, portal hypertension and alterations in blood clotting. These difficulties make 
conversion to laparotomy, mainly because of hemorrhages. In 27 patients with HCC 
resected by laparoscopy [Cherqui et al. (14)],  there was a 26% conversion rate (7 patients, 5 
of which were due to hemorrhage); 6 patients had blood losses greater than 1000 ml and 3 of 
these were given a blood transfusion (15%). Given the risk from bleeding, the authors 
systematically carry out the intermittent Pringle maneuver (taking a mean time of 55 min) 
and this could explain why they report a longer mean surgical time (240 min) (14). The 
technical difficulties were greater in the resection of tumours located in right lobe (even 
when patients were in the left lateral decubitus position) compared to tumours located in 
the left lateral segments (II and III segments).  
Due to the greater risk of bleeding during LLR for HCC, we propose the use of TACE. As 
the tumour is mainly irrigated through the artery, selective TACE of the segments to be 
resected could lead to less vascularization, and therefore, less bleeding during LR. 
Consequently, there might be less need to occlude the hepatic hilum (this would prevent 
secondary hepatic ischemia, and therefore there could be less risk of postoperative liver 
failure), less surgical time and less transfusion. This seems to have been confirmed in the 10 
patients in our series. In spite of several tumours being located in a position that makes 
tumour resection technically more difficult, when LLR was used, mean surgical time was 
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low (174 min, range 120-240 min), mean blood loss was scarce (220 ml, range 50-500 ml) and 
the Pringle maneuver was not needed.  
In our series, unlike other authors (14-16), the patient was placed in supine position even 
when the lesions were in the right lobe. In two cases we had to convert to HALLS but this 
was not due to bleeding, which is a factor that commonly leads to conversion in other series 
(24,25,28). In the first case the patient was converted in order to mobilize the right hepatic 
lobe enabling radiofrequency of a 2 cm nodule located posterior to the right hepatic vein 
(resection of segment VI had been carried out previously); and, in the second case, 
conversion to HALLS was necessary because of complete blockage of adhesions of the 
subhepatic space due to a cholecystectomy 20 years earlier.   
In other series, intraoperative bleeding is lower than the levels published by Cherqui et al. 
(14). Belli et al. (19) carried out a retrospective study comparing 23 patients with HCC on 
cirrhosis treated using LLR compared to another 23 treated using open surgery (OS). Blood 
loss (260 ml vs. 376 ml by OS), transfusion (0% vs. 17% by OS) and the Pringle maneuver 
(0% vs. 21% by OS) were lower in the LLR group, although surgical time was higher (148 
min vs. 125 min with OS). Furthermore, only 1 patient out of 23 was converted (4.3%), the 
tumour was located in S VI and there were difficulties in finding the tumour for resection, in 
spite of the patient being in lateral decubitus position. Perhaps these good results are related 
to the location of the tumour (50% in the left lobe) and due to greater patient selection given 
that all the tumours were subcapsular and exophitic. In this kind of tumour that is so 
peripheral, it would probably be inadvisable to carry out TACE.  
There have been many retrospective studies of open surgery (30-32) comparing patients 
operated on by LR for HCC on cirrhosis with and without TACE. For Choi et al. (31) 
there are no differences in the 5 year survival rates between both groups and for Chen 
et al. (32) survival at 5 years was greater in the group with TACE. What is more, Choi et 
al. (31) compared the operative results of both groups, revealing slightly higher blood 
loss rates in the group with TACE, without statistical differences. These results are in 
contrast to our results and we believe that this is because the groups are not comparable 
because the TACE was carried out on central tumours > 5 cm and a greater % of major 
LR was carried out.  
To conclude, selective TACE of the tumour and of the segments to be resected by 
laparoscopy, in patients in the early stages of HCC on Child A cirrhosis without portal 
hypertension, seems to reduce blood losses and the need for occluding the hilum, and any 
consequent complications of occlusion. Prospective randomized studies are needed with a 
greater number of patients comparing laparoscopic resection with and without TACE in 
selected cases of HCC on cirrhosis, in order to analyze the advantages in the immediate 
postoperative period and the possible effects on long term survival.   
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